Nordic Clinical Trials

The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) is a cohesive and extensive group of Neuro-Ophthalmologists, other doctors, coordinators, biostatisticians, clinical trial experts and reading centers, who have developed a structured organization to perform prospective clinical research with the support of the National Eye Institute of the NIH, other funding agencies, and industry.
Click here to read our mission statement

Current Research


  • Surgical IIH Treatment Trial – enrolling soon

    This trial is being conducted to compare medical treatment and two types of surgical treatments for Idiopathic Intracranial Hypertension. The trial will be enrolling subjects soon at hospital clinics and private practices around the US and Canada soon. Click here for a list of doctors who will be enrolling soon.

    NAION Clinical Trial - currently enrolling

    Quark Pharmaceuticals and NORDIC are collaborating on an investigational drug trial to evaluate a neuroprotection therapy for acute Non-arteritic Anterior Ischemic Optic Neuropathy (NAION). The trial is currently enrolling subjects who are 50-80 years old and have had sudden vision loss in one eye within the last 14 days. The trial is being conducted by Neuro-Ophthalmologists in private practices and in hospitals around the United States. The trial is also planned to open in India, Israel, Italy, Germany, Australia, and China.

    FIND a DOCTOR for NAION

    Patients
    If you have experienced recent, sudden vision loss in one eye and would like information on enrolling as a participant in the study, visit our NAION Clinical Trial Patient FAQ page for more information.

    Eye Care Specialists
    If you are an Eye Care Specialist and would like information on referring a patient to this trial, visit our NAION Clinical Trial Doctor Fact Sheet.
  • NORDIC has concluded a study on Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). IIH, also called pseudotumor cerebri, is a disorder of elevated intracranial pressure of unknown case. Its incidence is 22.5 new cases each year per 100,000 overweight women of childbearing age; its incidence is rising in parallel with the obesity epidemic. It affects about 100,000 Americans. Recruitment has concluded for this study. Learn More
  • The Pediatric Optic Neuritis Prospective Outcomes Study, a joint collaboration between NORDIC and the Pediatric Eye Disease Investigator Group (PEDIG), is now open to interested sites. This observational data collection study is funded by the National Eye Institute and will determine our investigators' ability to enroll children with optic neuritis into a research protocol, and help us develop estimates of visual acuity outcomes in these children. Treatment is at the discretion of the investigator. A small research payment is made to sites for each enrollment and follow up exam completed. If you are interested in participating, please email PEDIG@JAEB.ORG for further details. LEARN MORE